title: Fulminant hepatic failure and autoimmune disorders in patient with multiple sclerosis on interferon beta 1a: a fatal combination?
authors.forename: Giada
authors.initials: G
authors.lastname: Pietrosi
authors.forename: Lucio
authors.initials: L
authors.lastname: Mandala
authors.forename: Giovanni B
authors.initials: GB
authors.lastname: Vizzini
authors.forename: Salvatore
authors.initials: S
authors.lastname: Gruttadauria
authors.forename: Marta I
authors.initials: MI
authors.lastname: Minervini
authors.forename: Gaetano
authors.initials: G
authors.lastname: Burgio
authors.forename: Aldo
authors.initials: A
authors.lastname: Spadaro
authors.forename: Bruno
authors.initials: B
authors.lastname: Gridelli
mesh_terms: D001327:Autoimmune Diseases / Q000209:etiology*; D005260:Female; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000009:adverse effects*; D017114:Liver Failure, Acute / Q000209:etiology*; D016031:Liver Transplantation; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications* / Q000188:drug therapy
chemical_list: D016899:Interferon-beta; D000068556:Interferon beta-1a